Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV prevention
Pharma
MSF decries Gilead's updated global access plan for Yeztugo
Gilead expanded its commitment to bring Yeztugo to 3 million people worldwide, but MSF says supply is still "not nearly enough."
Zoey Becker
Apr 15, 2026 12:14pm
'One2PrEP': Gilead's 1st Yeztugo ad highlights biannual dosing
Mar 2, 2026 3:39pm
‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec
Feb 11, 2026 11:34am
CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo
Sep 19, 2025 11:22am
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
With FDA nod, Gilead adds twice-yearly option to PrEP landscape
Jun 18, 2025 2:32pm
